Re-aligning scientific and lay narratives of Alzheimer's disease

Integrating frailty into decision-making for disease-modifying therapies in Alzheimer's disease: a proposed expert-opinion based approach.

The journal of prevention of Alzheimer's disease·2026

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

JAMA·2026

Alzheimer's disease.

Lancet (London, England)·2026

Retinal biomarkers for early Alzheimer's detection: a systematic review of optical coherence tomography (OCT) findings.

BMJ open ophthalmology·2026

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

International consensus for the assessment of social cognition in neurocognitive disorders: framework definition and clinical recommendations of the SIGNATURE initiative.

Alzheimer's research & therapy·2025

Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study.

The Lancet. Neurology·2026

Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies.

The Lancet. Neurology·2026

Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change.

The Lancet. Neurology·2026

Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.

The Lancet. Neurology·2026

Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders.

The Lancet. Neurology·2026

Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Neurology·2026

Normal Alanine Aminotransferase Levels Underestimate the Burden of Steatotic Liver Disease and Fibrosis in US Adults.

The American journal of medicine·2026

Investigating the DTI-ALPS index and its association with cognitive impairment in Alzheimer's disease: a diffusion tensor imaging study.

Frontiers in neuroscience·2026

Aberrant Left Subclavian Artery Hypoplasia with Right Aortic Arch as a Cause of Inter-arm Blood Pressure Difference and Subclavian Steal in an Asymptomatic Adult.

Internal medicine (Tokyo, Japan)·2026

Functional validation of the Plasmodium falciparum K13 C580Y mutation in recently collected Ethiopian isolates.

Antimicrobial agents and chemotherapy·2026

Expert opinion on Alzheimer's disease diagnostics and management in Central Eastern European countries representing 88 million population.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026

Evaluating classification approaches for population affinity estimation in a contemporary South African CT-derived sample: an automatic landmarking-based approach.

International journal of legal medicine·2026

Related Experiment Videos

Re-aligning scientific and lay narratives of Alzheimer's disease

Related Concept Videos

Integrating frailty into decision-making for disease-modifying therapies in Alzheimer's disease: a proposed expert-opinion based approach.

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Alzheimer's disease.

Retinal biomarkers for early Alzheimer's detection: a systematic review of optical coherence tomography (OCT) findings.

Drug Development.

International consensus for the assessment of social cognition in neurocognitive disorders: framework definition and clinical recommendations of the SIGNATURE initiative.

Dynamic changes in plasma biomarkers of Alzheimer's disease in patients treated with lecanemab: a longitudinal cohort study.

Plasma phosphorylated tau 217 concentrations, APOE genotype, and timing of cognitive impairment in individuals across diverse racial and ethnic groups: a pooled analysis of prospective cohort studies.

Clinical pathways for cognitively unimpaired individuals with Alzheimer's disease neuropathological change.

Neuroimaging in the era of biologically defined Alzheimer's disease and disease-modifying therapy.

Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders.

Safety, tolerability, and efficacy of RIPK1 inhibitor, SAR443820, in amyotrophic lateral sclerosis (HIMALAYA): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Normal Alanine Aminotransferase Levels Underestimate the Burden of Steatotic Liver Disease and Fibrosis in US Adults.

Investigating the DTI-ALPS index and its association with cognitive impairment in Alzheimer's disease: a diffusion tensor imaging study.

Aberrant Left Subclavian Artery Hypoplasia with Right Aortic Arch as a Cause of Inter-arm Blood Pressure Difference and Subclavian Steal in an Asymptomatic Adult.

Functional validation of the Plasmodium falciparum K13 C580Y mutation in recently collected Ethiopian isolates.

Expert opinion on Alzheimer's disease diagnostics and management in Central Eastern European countries representing 88 million population.

Evaluating classification approaches for population affinity estimation in a contemporary South African CT-derived sample: an automatic landmarking-based approach.

Related Experiment Videos

Re-aligning scientific and lay narratives of Alzheimer's disease

Related Concept Videos

Related Articles